⌕
Sana Biotechnology · SANA · Nasdaq
Tenet 36 · Weak
Compare
$1.880.00%At closeTenet 36 · Weak
$1.880.00 (0.00%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Sana Biotechnology (SANA) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is SANA's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Zacks Investment ResearchNov 16, 2026 · 10:56 ET
Bears are Losing Control Over Sana (SANA), Here's Why It's a 'Buy' Now

Sana (SANA) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the sto…

SANA 0.0% todayRead at source ↗
● GlobeNewsWireNov 5, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates

Continued progress toward starting SC451 Phase 1/2 trial in type 1 diabetes Continued progress toward starting clinical study for SG293 in non-Hodgkin lymphoma Announced follow-on publication in The New England Journal o…

SANA 0.0% todayRead at source ↗
● Seeking AlphaOct 13, 2026 · 06:04 ET
Sana Biotechnology: A Shot At Diabetes

Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. UP421 demonstrated durable insulin production without immunosuppression in early data, positioning SANA as a potential T1D disru…

SANA 0.0% todayRead at source ↗
● Seeking AlphaSep 14, 2026 · 20:41 ET
Sana Biotechnology, Inc. (SANA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript…

SANA 0.0% todayRead at source ↗
● Seeking AlphaSep 10, 2026 · 16:47 ET
Sana Biotechnology, Inc. (SANA) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Sana Biotechnology, Inc. (SANA) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript…

SANA 0.0% todayRead at source ↗
● Seeking AlphaSep 10, 2026 · 10:57 ET
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript…

SANA 0.0% todayRead at source ↗
● PRNewsWireSep 7, 2026 · 15:09 ET
Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket p…

SANA 0.0% todayRead at source ↗
● GlobeNewsWireSep 1, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Sana Biotechnology to Present at September 2026 Investor Conferences

SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation…

SANA 0.0% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA29−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just SANA · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.